Royce & Associates’s Legence Corp LGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.7M Buy
366,853
+28,978
+9% +$1.46M 0.2% 137
2025
Q4
$14.5M Buy
337,875
+305,865
+956% +$12.1M 0.15% 209
2025
Q3
$986K Buy
+32,010
New +$1.01M 0.01% 668

Other funds holding LGN

Royce & Associates's LGN Position: Q1 2026 in Review

Royce & Associates increased its Legence Corp (LGN) stake by 8.6% in Q1 2026, buying an estimated $1.46M and bringing the position to 366,853 shares worth $20.7M. The position accounts for 0.2% of the portfolio, ranked #137.

Royce & Associates first reported a position in LGN in Q3 2025 and has held it in 3 quarters since. 197 funds tracked by Wall St. Rank hold LGN as of Q1 2026.

  • Royce & Associates held 366,853 shares of Legence Corp worth $20.7M as of Q1 2026.
  • Royce & Associates bought 28,978 Legence Corp shares in Q1 2026, an estimated $1.46M.
  • Legence Corp made up 0.2% of Royce & Associates's portfolio in Q1 2026, its #137 holding.
  • Royce & Associates first reported a position in Legence Corp in Q3 2025 and has held it in 3 quarters since.
  • 197 funds tracked by Wall St. Rank held Legence Corp as of Q1 2026.

Based on Royce & Associates's 13F filing for Q1 2026, filed 12 May 2026.